IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — GSK

Balance Sheet

(in billions GBP)
MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Cash & Equivalents3.403.872.943.724.276.294.71
Inventory5.925.675.505.155.786.005.95
Total Current Assets17.5117.0018.6420.7718.6720.2519.49
Goodwill7.026.986.817.0510.5510.6010.56
Total Non-current Assets43.6142.4740.3639.3860.4360.1860.20
Total Assets61.1259.4659.0160.1579.1080.4379.69
Total Current Liabilities21.3921.7021.0722.8123.6722.1524.05
Total Non-current Liabilities23.7724.6825.1427.2434.0937.4837.28
Total Liabilities45.1646.3846.2150.0557.7659.6261.34
Retained Earnings10.217.807.244.367.946.764.53
Total Stockholder Equity15.9613.0912.8010.1021.3420.8118.36

Income Statement

(in billions GBP) (except per-share rows)
MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Total Revenue32.6731.3830.3329.3234.1134.1033.75
Cost of Revenue*9.029.058.579.5511.6011.7011.86
Gross Profit23.6522.3321.7619.7722.5122.4021.89
Research & Development7.536.406.225.495.285.104.57
Selling, General & Admin9.0911.029.398.3710.9811.4611.40
Total Operating Expenses*15.7218.3115.0213.3416.3114.6114.93
Operating Income7.934.026.756.436.207.786.96
Interest Expense------0.910.78----
Pretax Income7.403.486.065.635.446.976.22
Tax Provision1.110.530.760.710.350.580.95
Net Income6.292.955.3115.625.106.395.27
Basic EPS1.410.631.223.710.881.160.94
Diluted EPS1.390.621.203.660.871.140.93

* Derived from reported values

Cash Flow Statement

(in billions GBP)
MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Operating Cash Flow7.746.556.777.407.958.448.02
Investing Cash Flow(4.23)(1.23)(1.59)(8.77)(1.78)2.16(5.35)
Financing Cash Flow(3.68)(4.73)(5.64)0.82(7.59)(10.13)(1.84)